198 related articles for article (PubMed ID: 26223194)
1. MYC Analysis by Fluorescent In Situ Hybridization and Immunohistochemistry in Primary Adrenal Angiosarcoma (PAA): a Series of Four Cases.
Cornejo KM; Hutchinson L; Cyr MS; Nose V; McLaughlin PJ; Iafrate AJ; Sadow PM
Endocr Pathol; 2015 Dec; 26(4):334-41. PubMed ID: 26223194
[TBL] [Abstract][Full Text] [Related]
2. FISH for MYC amplification and anti-MYC immunohistochemistry: useful diagnostic tools in the assessment of secondary angiosarcoma and atypical vascular proliferations.
Fernandez AP; Sun Y; Tubbs RR; Goldblum JR; Billings SD
J Cutan Pathol; 2012 Feb; 39(2):234-42. PubMed ID: 22121953
[TBL] [Abstract][Full Text] [Related]
3. Oral and salivary gland angiosarcoma: a clinicopathologic study of 29 cases.
Fanburg-Smith JC; Furlong MA; Childers EL
Mod Pathol; 2003 Mar; 16(3):263-71. PubMed ID: 12640107
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical and Fluorescence In Situ Hybridization Analysis of MYC in a Series of 17 Cutaneous Angiosarcomas: A Single-Center Study.
Requena C; Rubio L; Lavernia J; Machado I; Llombart B; Sanmartín O; Traves V; Guillén C; Cruz J
Am J Dermatopathol; 2018 May; 40(5):349-354. PubMed ID: 29135507
[TBL] [Abstract][Full Text] [Related]
5. Fully automated dual-color dual-hapten silver in situ hybridization staining for MYC amplification: a diagnostic tool for discriminating secondary angiosarcoma.
Ko JS; Billings SD; Lanigan CP; Buehler D; Fernandez AP; Tubbs RR
J Cutan Pathol; 2014 Mar; 41(3):286-92. PubMed ID: 24329959
[TBL] [Abstract][Full Text] [Related]
6. MYC amplification and overexpression in primary cutaneous angiosarcoma: a fluorescence in-situ hybridization and immunohistochemical study.
Shon W; Sukov WR; Jenkins SM; Folpe AL
Mod Pathol; 2014 Apr; 27(4):509-15. PubMed ID: 24091875
[TBL] [Abstract][Full Text] [Related]
7. Angiosarcoma and atypical vascular lesions of the breast: diagnostic and prognostic role of MYC gene amplification and protein expression.
Fraga-Guedes C; André S; Mastropasqua MG; Botteri E; Toesca A; Rocha RM; Peradze N; Rotmensz N; Viale G; Veronesi P; Gobbi H
Breast Cancer Res Treat; 2015 May; 151(1):131-40. PubMed ID: 25893585
[TBL] [Abstract][Full Text] [Related]
8. Recurrent CIC Gene Abnormalities in Angiosarcomas: A Molecular Study of 120 Cases With Concurrent Investigation of PLCG1, KDR, MYC, and FLT4 Gene Alterations.
Huang SC; Zhang L; Sung YS; Chen CL; Kao YC; Agaram NP; Singer S; Tap WD; D'Angelo S; Antonescu CR
Am J Surg Pathol; 2016 May; 40(5):645-55. PubMed ID: 26735859
[TBL] [Abstract][Full Text] [Related]
9. MYC gene amplification by fluorescence in situ hybridization and MYC protein expression by immunohistochemistry in the diagnosis of cutaneous angiosarcoma: Systematic review and appropriate use criteria.
Motaparthi K; Lauer SR; Patel RM; Vidal CI; Linos K
J Cutan Pathol; 2021 Apr; 48(4):578-586. PubMed ID: 33128474
[TBL] [Abstract][Full Text] [Related]
10. MYC amplification in angiosarcomas arising in the setting of chronic lymphedema of morbid obesity.
Harker D; Jennings M; McDonough P; Mauskar M; Savory S; Hosler GA; Vandergriff T
J Cutan Pathol; 2017 Jan; 44(1):15-19. PubMed ID: 27686553
[TBL] [Abstract][Full Text] [Related]
11. Chromosome 8 Polysomy Accounting for MYC Over-Expression in Angiosarcoma Arising as Somatic-Type Malignancy in Metastatic Teratoma. Case Report.
Vargas AC; Grimison P; Joy C; Garrone B; Bonar F; Ghahan RM; Davidson T; Maclean FM
Int J Surg Pathol; 2022 Jun; 30(4):462-465. PubMed ID: 34955058
[TBL] [Abstract][Full Text] [Related]
12. The utility of MYC and FLT4 in the diagnosis and treatment of postradiation atypical vascular lesion and angiosarcoma of the breast.
Cornejo KM; Deng A; Wu H; Cosar EF; Khan A; St Cyr M; Tomaszewicz K; Dresser K; O'Donnell P; Hutchinson L
Hum Pathol; 2015 Jun; 46(6):868-75. PubMed ID: 25864386
[TBL] [Abstract][Full Text] [Related]
13. Postradiation cutaneous angiosarcoma after treatment of breast carcinoma is characterized by MYC amplification in contrast to atypical vascular lesions after radiotherapy and control cases: clinicopathological, immunohistochemical and molecular analysis of 66 cases.
Mentzel T; Schildhaus HU; Palmedo G; Büttner R; Kutzner H
Mod Pathol; 2012 Jan; 25(1):75-85. PubMed ID: 21909081
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic evaluation of MYC expression in primary mediastinal (thymic) large B-cell lymphoma.
Li KD; Miles R; Tripp SR; Glenn MJ; Perkins SL; Salama M
Am J Clin Pathol; 2015 Apr; 143(4):598-604. PubMed ID: 25780014
[TBL] [Abstract][Full Text] [Related]
15. Angiosarcoma arising in association with vascular Dacron grafts and orthopedic joint prostheses: clinicopathologic, immunohistochemical, and molecular study.
Agaimy A; Ben-Izhak O; Lorey T; Scharpf M; Rubin BP
Ann Diagn Pathol; 2016 Apr; 21():21-8. PubMed ID: 27040926
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic utility of MYC amplification and anti-MYC immunohistochemistry in atypical vascular lesions, primary or radiation-induced mammary angiosarcomas, and primary angiosarcomas of other sites.
Ginter PS; Mosquera JM; MacDonald TY; D'Alfonso TM; Rubin MA; Shin SJ
Hum Pathol; 2014 Apr; 45(4):709-16. PubMed ID: 24457083
[TBL] [Abstract][Full Text] [Related]
17. c-MYC amplification and c-myc protein expression in pancreatic acinar cell carcinomas. New insights into the molecular signature of these rare cancers.
La Rosa S; Bernasconi B; Vanoli A; Sciarra A; Notohara K; Albarello L; Casnedi S; Billo P; Zhang L; Tibiletti MG; Sessa F
Virchows Arch; 2018 Oct; 473(4):435-441. PubMed ID: 29721608
[TBL] [Abstract][Full Text] [Related]
18. Epithelioid angiosarcoma of the adrenal glands. A clinicopathologic study of nine cases with a discussion of the implications of finding "epithelial-specific" markers.
Wenig BM; Abbondanzo SL; Heffess CS
Am J Surg Pathol; 1994 Jan; 18(1):62-73. PubMed ID: 8279629
[TBL] [Abstract][Full Text] [Related]
19. Primary cutaneous epithelioid angiosarcoma: a clinicopathologic study of 13 cases of a rare neoplasm occurring outside the setting of conventional angiosarcomas and with predilection for the limbs.
Suchak R; Thway K; Zelger B; Fisher C; Calonje E
Am J Surg Pathol; 2011 Jan; 35(1):60-9. PubMed ID: 21164288
[TBL] [Abstract][Full Text] [Related]
20. Array CGH analysis identifies two distinct subgroups of primary angiosarcoma of bone.
Verbeke SL; de Jong D; Bertoni F; Sciot R; Antonescu CR; Szuhai K; Bovée JV
Genes Chromosomes Cancer; 2015 Feb; 54(2):72-81. PubMed ID: 25231439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
